Subhanu Saxena is a Managing Partner at New Rhein. He previously held executive leadership roles at Cipla and Novartis.
At firms with a similar stage, sector and check size.
One email when Subhanu's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckSubhanu Saxena is a Managing Partner at New Rhein. He previously held executive leadership roles at Cipla and Novartis.
New Rhein has not reported a check size. It invests at series a, series b.
Email [email protected], the firm's inbox for founders, and name Subhanu in the subject. A warm intro from a founder New Rhein backed works better.
Country President and Pharma CEO at Novartis UK and Ireland; Pharma Executive Committee Member at Novartis Pharmaceuticals; Managing Director & Global Chief Executive Officer at Cipla.
Last updated 2026-10-15. Is this you? Ask for a correction.